Katie Rowley

FDA Drug Recalls and Warnings

FDA Recalls and Warnings: Potentially Contaminated Cough Drops and Eye Drops, Subpotent Thyroid Medications & More

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns…

Apr 13, 2026

FDA Side Effect Updates

FDA SIDE EFFECTS UPDATE: Risk of Serotonin Syndrome With Antibiotic, Severe Bleeding with Blood Thinner

Welcome to the FDA Side Effects Update. This series is designed to keep you informed about the latest safety advisories and newly documented side effects…

Apr 8, 2026

FDA Drug Recalls and Warnings

FDA Drug Recalls and Warnings: Foreign Substances in Children’s Ibuprofen, ED Drugs in Supplements, and More

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns…

Mar 23, 2026

FDA Drug Recalls and Warnings

FDA Drug Recalls and Warnings: Common Blood Pressure Drug May Not Dissolve Properly, Novo Nordisk Warned

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns…

Mar 12, 2026

FDA Side Effect Updates

FDA SIDE EFFECTS UPDATE: Osteoporosis Drugs and New Bone Fracture Risks

Welcome to the FDA Side Effects Update. This series is designed to keep you informed about the latest safety advisories and newly documented side effects…

Mar 3, 2026

FDA Drug Recalls and Warnings

FDA Drug Recalls and Warnings: Cancer-Linked Impurities in Blood Pressure Drug; Unsanitary U.S. Facilities Flagged

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns…

Feb 10, 2026

FDA Side Effect Updates

FDA SIDE EFFECTS UPDATE: Bupropion Antidepressants and the Risk of Drug-Induced Meningitis

Welcome to the FDA Side Effects Update. This series is designed to keep you informed about the latest safety advisories and newly documented side effects…

Feb 2, 2026

FDA Side Effect Updates

FDA SIDE EFFECTS UPDATE: New Warnings for Stelara, Tepezza, and Other Autoimmune Drugs

Welcome to the FDA Side Effects Update. This series is designed to keep you informed about the latest safety advisories and newly documented side effects…

Jan 8, 2026

FDA Side Effect Updates

FDA SIDE EFFECTS UPDATE: Botox, Briumvi, Fragmin, Heparin, Jubbonti

Welcome to the FDA Side Effects Update. This new series is designed to keep you informed about the latest safety advisories and newly documented side…

Nov 8, 2024

FDA Drug Recalls and Warnings

FDA Drug Recalls and Warnings: Eye Drops Recall; Clinical Trials Violations

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns…

Jul 16, 2025

FDA Side Effect Updates

FDA SIDE EFFECTS UPDATE: Depo Provera and Brain Tumors, Veozah Boxed Warning And More

Welcome to the FDA Side Effects Update. This series is designed to keep you informed about the latest safety advisories and newly documented side effects…

Jan 13, 2025

FDA Drug Recalls and Warnings

FDA Drug Recalls and Warnings: Serious Risks of Unapproved Botox Injectables

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns…

Dec 10, 2025

GLP-1s, FDA Drug Recalls and Warnings

FDA Drug Recalls and Warnings: Sterility Issues in Compounded GLP-1s, Antidepressants With Elevated Cancer-Linked Chemicals and More

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns…

Dec 3, 2025

FDA Side Effect Updates

FDA SIDE EFFECTS UPDATE: New Liver Injury Warnings for MS Drugs and Epilepsy Treatment

Welcome to the FDA Side Effects Update. This series is designed to keep you informed about the latest safety advisories and newly documented side effects…

Nov 12, 2025

FDA Drug Recalls and Warnings

FDA Drug Recalls and Warnings: Blood Pressure Meds Tainted With Cancer-Causing Chemicals, Gabapentin Impurities and More

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns…

Oct 31, 2025

FDA Drug Recalls and Warnings

FDA Drug Recalls and Warnings: Atorvastatin; Labeling Mix-Up with Muscle Relaxant Cyclobenzaprine, and More

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns…

Oct 23, 2025

FDA Drug Recalls and Warnings

FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns…

Oct 15, 2025

FDA Side Effect Updates

FDA SIDE EFFECTS UPDATE: Testosterone Drugs and High Blood Pressure Risk

Welcome to the FDA Side Effects Update. This series is designed to keep you informed about the latest safety advisories and newly documented side effects…

Oct 1, 2025

GLP-1s, FDA Drug Recalls and Warnings

FDA Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility Warning Letters

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns…

Sep 18, 2025

FDA Drug Recalls and Warnings

FDA Drug Recalls and Warnings: Recalls for Glaucoma Eye Medications and Allergy Eye Drops

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns…

Sep 4, 2025